Table 3 Recurrence of metastasis from hepatocellular carcinoma after the first pulmonary metastasectomy
| Â | Total (n = 134) | Open (n = 50) | VATS (n = 84) | p value |
|---|---|---|---|---|
Recurrence after metastasectomy | 113 (84.3%) | 42 (84.0%) | 71 (84.5%) | 0.936 |
Recurred site | Â | Â | Â | 0.581 |
 Lung | 63 (47.0%) | 27 (54.0%) | 36 (42.9%) | |
 Liver | 26 (19.4%) | 9 (18.0%) | 17 (20.2%) | |
 Bone | 0 | 0 | 0 | |
 Brain | 2 (1.5%) | 1 (2.0%) | 1 (1.2%) | |
 Different single organ | 13 (9.7%) | 2 (4.0%) | 11 (13.1%) | |
 Multiple organs | 9 (6.7%) | 3 (6.0%) | 6 (7.1%) | |
Pulmonary specific recurrence | 95 (70.9%) | 38 (76.0%) | 57 (67.9%) | 0.316 |
Recurred site | Â | Â | Â | 0.297 |
 Ipsilateral | 43 (32.1%) | 20 (40.0%) | 23 (27.4%) | |
 Contralateral | 52 (38.8%) | 18 (36.0%) | 34 (40.5%) | |
Treatment of recurred PM | Â | Â | Â | 0.533 |
 Surgery | 45 (33.6%) | 18 (36.0%) | 27 (32.1%) | |
 Chemotherapy | 27 (20.1%) | 10 (20.0%) | 17 (20.2%) | |
 Radiotherapy | 4 (3.0%) | 2 (4.0%) | 2 (2.4%) | |
 Chemoradiation | 2 (1.5%) | 2 (4.0%) | 0 | |
 Observation | 17 (12.7%) | 6 (12.0%) | 11 (13.2%) |